Jean Marc D.
- Country
- France
- Department
- Pneumologie
Research Overview
- Evaluation of Benralizumab's Predictive Gene Expression Signature in Reducing Exacerbations in Severe Asthma Patients
- Evaluation of Budesonide, Glycopyrronium Bromide, and Formoterol Fumarate on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease Patients
- Evaluation of Benralizumab Efficacy and Safety in Eosinophilic Asthma Patients Uncontrolled on Medium-Dose ICS-LABA Therapy
Data & Insights
Has run more than one trial at 57 of 368 partner sites.
Specializations
Respiratory Medicine
This investigator specializes in the treatment of severe respiratory conditions, with particular emphasis on eosinophilic asthma and its various manifestations.
- Severe Asthma Management
- Eosinophilic Inflammation
- Advanced Treatment Protocols
The investigator explores innovative therapeutic approaches for patients with uncontrolled asthma conditions.
Therapeutic Innovation
Research interests center on biological therapies for severe asthma, particularly investigating treatment responses in patients with difficult-to-control symptoms.
- Biological Treatment Assessment
- Treatment Response Prediction
- Gene Expression Analysis
The focus includes evaluating therapeutic efficacy in cases resistant to standard treatments.
Clinical Assessment
Expertise in clinical biomarker research and the development of predictive treatment models for respiratory conditions.
- Biomarker Evaluation
- Treatment Response Patterns
- Clinical Outcome Assessment
The investigator evaluates treatment efficacy through comprehensive clinical assessment protocols.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.